Skip to content

APOTHEEK BOUAKKA: what changed

BE 0837.524.724NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€48,582
2024 · €29,424+€19,158
Equity
€282,809
2024 · €267,358+€15,452
Cash
€116,681
2024 · €104,535+€12,146
Balance sheet total
€394,063
2024 · €328,243+€65,821

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€33,809

    up €33,809 (+33.8%), from €100,099 to €133,908

    of which Other amounts receivable: +€30,558

  • Stocks and contracts +€22,125

    up €22,125 (+30.6%), from €72,383 to €94,508

  • Cash +€12,146

    up €12,146 (+11.6%), from €104,535 to €116,681

    mainly Net result for the year (+€48,582) and Other debts (+€33,130)

Equity and liabilities
  • Other debts +€33,130

    new in 2025: €33,130

  • Reserves +€15,452

    up €15,452 (+9.9%), from €156,271 to €171,722

  • Tax, wage and social debts +€10,282

    up €10,282 (+77.7%), from €13,227 to €23,508

    of which Taxes: +€9,964

  • Trade debts +€5,909

    up €5,909 (+15.2%), from €38,947 to €44,856

Income statement
  • Gross operating margin +€30,044

    up €30,044 (+21.8%), from €137,743 to €167,787

  • Taxes +€7,354

    up €7,354 (+64.4%), from €11,426 to €18,780

  • Financial charges +€3,860

    up €3,860 (+33.2%), from €11,627 to €15,486

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €29,424
Gross operating margin +€30,044
Staff costs +€399
Depreciation +€0
Other operating charges -€25
Financial income -€46
Financial charges -€3,860
Taxes -€7,354
Result 2025 €48,582
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€45,276
Investment €0
Financing -€33,130
Cash 2024 €104,535
Net result for the year +€48,582
Depreciation +€2,536
Stocks and contracts -€22,125
Receivables within one year -€33,809
Deferred charges and accrued income -€276
Trade debts +€5,909
Tax, wage and social debts +€10,282
Other debts +€33,130
Accrued charges and deferred income +€1,048
Contributions, distributions and other -€33,130
Cash 2025 €116,681
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €328,243 €394,063 +€65,821 +20.1%
Fixed assets 21/28 €5,019 €2,483 -€2,536 -50.5%
Tangible fixed assets 22/27 €5,019 €2,483 -€2,536 -50.5%
Plant, machinery and equipment 23 €5,019 €2,483 -€2,536 -50.5%
Current assets 29/58 €323,224 €391,580 +€68,356 +21.1%
Stocks and contracts in progress 3 €72,383 €94,508 +€22,125 +30.6%
Stocks 30/36 €72,383 €94,508 +€22,125 +30.6%
Amounts receivable within one year 40/41 €100,099 €133,908 +€33,809 +33.8%
Trade receivables 40 €68,766 €72,016 +€3,250 +4.7%
Other amounts receivable 41 €31,333 €61,891 +€30,558 +97.5%
Current investments 50/53 €30,276 €30,276 = 0.0%
Cash at bank and in hand 54/58 €104,535 €116,681 +€12,146 +11.6%
Deferred charges and accrued income 490/1 €15,930 €16,207 +€276 +1.7%
Total equity and liabilities 10/49 €328,243 €394,063 +€65,821 +20.1%
Equity 10/15 €267,358 €282,809 +€15,452 +5.8%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €156,271 €171,722 +€15,452 +9.9%
Distributable reserves 133 €156,271 €171,722 +€15,452 +9.9%
Profit (loss) carried forward 14 €92,487 €92,487 = 0.0%
Amounts payable 17/49 €60,885 €111,254 +€50,369 +82.7%
Amounts payable within one year 42/48 €52,173 €101,494 +€49,321 +94.5%
Trade debts 44 €38,947 €44,856 +€5,909 +15.2%
Suppliers 440/4 €38,947 €44,856 +€5,909 +15.2%
Taxes, remuneration and social security 45 €13,227 €23,508 +€10,282 +77.7%
Taxes 450/3 €2,674 €12,639 +€9,964 +373%
Remuneration and social security 454/9 €10,552 €10,870 +€318 +3.0%
Other amounts payable 47/48 - €33,130 +€33,130
Accrued charges and deferred income 492/3 €8,712 €9,759 +€1,048 +12.0%
Remuneration, social security and pensions 62 €85,344 €84,945 -€399 -0.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,536 €2,536 -€0 0.0%
Other operating charges 640/8 €839 €864 +€25 +3.0%
Gross operating margin 9900 €137,743 €167,787 +€30,044 +21.8%
Operating profit (loss) 9901 €49,023 €79,442 +€30,418 +62.0%
Financial income 75/76B €3,453 €3,406 -€46 -1.3%
Recurring financial income 75 €3,453 €3,406 -€46 -1.3%
Financial charges 65/66B €11,627 €15,486 +€3,860 +33.2%
Recurring financial charges 65 €11,627 €15,486 +€3,860 +33.2%
Profit (loss) for the period before taxes 9903 €40,850 €67,362 +€26,512 +64.9%
Income taxes 67/77 €11,426 €18,780 +€7,354 +64.4%
Profit (loss) for the period 9904 €29,424 €48,582 +€19,158 +65.1%
Profit (loss) for the period to be appropriated 9905 €29,424 €48,582 +€19,158 +65.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€264,176 to €313,285

Midpoint €284,638 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €282,809
Capitalised earnings €245,543 to €343,760
Indication €264,176 to €313,285

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€282,809
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€282,809

Capitalised earnings

net result for the year (9904)
2025
€48,582
2024
€29,424
2023
€25,122
2022
€22,840
2021
€43,895
Average result
€34,376
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€245,543 / €286,467 / €343,760

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 8 November 2026 via checked.be.